Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (501-510 of 569) with videos related to

Pageof 57
Sort By:
Cancer Immunology Research|September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous MelanomasJarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
JAMA Dermatology|November 3, 2021
Association Between Melanoma Detected During Routine Skin Checks and MortalityCaroline G Watts, Kirstie McLoughlin, Chris Goumas, et al.
Nature Communications|November 8, 2018
Epigenetic profiling for the molecular classification of metastatic brain tumorsJavier I J Orozco, Theo A Knijnenburg, Ayla O Manughian-Peter, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Journal of Translational Medicine|September 5, 2022
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation settingMathias Seviiri, Richard A Scolyer, D Timothy Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Final version of 2009 AJCC melanoma staging and classificationCharles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesSydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.
Australian Journal of General Practice|May 29, 2020
Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma managementCaroline G Watts, Andrea L Smith, Sam Robinson, et al.
The Lancet. Oncology|June 8, 2019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF<sup>V600</sup> mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trialGeorgina V Long, Robyn P M Saw, Serigne Lo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging databaseJohn F Thompson, Seng-Jaw Soong, Charles M Balch, et al.
Pageof 57

Showing results (501-510 of 569) with videos related to

Sort By:
Pageof 57
Cancer Immunology Research|September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous MelanomasJarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
JAMA Dermatology|November 3, 2021
Association Between Melanoma Detected During Routine Skin Checks and MortalityCaroline G Watts, Kirstie McLoughlin, Chris Goumas, et al.
Nature Communications|November 8, 2018
Epigenetic profiling for the molecular classification of metastatic brain tumorsJavier I J Orozco, Theo A Knijnenburg, Ayla O Manughian-Peter, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Journal of Translational Medicine|September 5, 2022
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation settingMathias Seviiri, Richard A Scolyer, D Timothy Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Final version of 2009 AJCC melanoma staging and classificationCharles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesSydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.
Australian Journal of General Practice|May 29, 2020
Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma managementCaroline G Watts, Andrea L Smith, Sam Robinson, et al.
The Lancet. Oncology|June 8, 2019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF<sup>V600</sup> mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trialGeorgina V Long, Robyn P M Saw, Serigne Lo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging databaseJohn F Thompson, Seng-Jaw Soong, Charles M Balch, et al.
Pageof 57